Cardiovascular risks impact human brain Nacetylaspartate in regionally specific patterns
JournalProceedings of the National Academy of Sciences of the United States of America
PublisherNational Academy of Sciences
MetadataShow full item record
AbstractCardiovascular risk factors such as dyslipidemia and hypertension increase the risk for white matter pathology and cognitive decline. We hypothesize that white matter levels of N-acetylaspartate (NAA), a chemical involved in the metabolic pathway for myelin lipid synthesis, could serve as a biomarker that tracks the influence of cardiovascular risk factors on white matter prior to emergence of clinical changes. To test this, we measured levels of NAA across white matter and gray matter in the brain using echo planar spectroscopic imaging (EPSI) in 163 individuals and examined the relationship of regional NAA levels and cardiovascular risk factors as indexed by the Framingham Cardiovascular Risk Score (FCVRS). NAA was strongly and negatively correlated with FCVRS across the brain, but, after accounting for age and sex, the association was found primarily in white matter regions, with additional effects found in the thalamus, hippocampus, and cingulate gyrus. FCVRS was also negatively correlated with creatine levels, again primarily in white matter. The results suggest that cardiovascular risks are related to neurochemistry with a predominantly white matter pattern and some subcortical and cortical gray matter involvement. NAA mapping of the brain may provide early surveillance for the potential subclinical impact of cardiovascular and metabolic risk factors on the brain.
SponsorsThis work was supported by NIH Grants K23MH112010, U01MH108148, R01MH116948, R01MH112180, R01MH094520, and P50 MH103222. The EPSI and MIDAS software are supported by NIH Grant R01EB016064.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85076351700&doi=10.1073%2fpnas.1907730116&partnerID=40&md5=e84c2de41a08d6feb00b0bf2a2530105; http://hdl.handle.net/10713/12817
- Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
- Authors: Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C
- Issue date: 2017 May 1
- Gray and white matter brain chemistry in young children with autism.
- Authors: Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR
- Issue date: 2006 Jul
- Hyperperfusion of Frontal White and Subcortical Gray Matter in Autism Spectrum Disorder.
- Authors: Peterson BS, Zargarian A, Peterson JB, Goh S, Sawardekar S, Williams SCR, Lythgoe DJ, Zelaya FO, Bansal R
- Issue date: 2019 Apr 1
- Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
- Authors: MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW
- Issue date: 1996 Feb
- Effects of Aging on the Human Brain: A Proton and Phosphorus MR Spectroscopy Study at 3T.
- Authors: Schmitz B, Wang X, Barker PB, Pilatus U, Bronzlik P, Dadak M, Kahl KG, Lanfermann H, Ding XQ
- Issue date: 2018 Jul